Financials in USD. Standardized financial statements.
A compact view of how MorphoSys AG turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $238.28M | $278.27M | $179.60M | $327.70M | $71.76M | $76.44M | $66.79M | $49.74M | $106.22M | $63.98M |
| Revenue Growth? | -14.4% | +54.9% | -45.2% | +356.7% | -6.1% | +14.5% | +34.3% | -53.2% | +66.0% | 0.0% |
| Cost of Revenue? | $58.35M | $48.62M | $32.20M | $9.17M | $12.09M | $5.55M | $33,000 | $97,000 | $77,000 | $77,000 |
| Gross Profit? | $179.92M | $229.65M | $147.40M | $318.52M | $59.67M | $70.90M | $66.76M | $49.65M | $106.15M | $63.90M |
| Gross Margin? | +75.5% | +82.5% | +82.1% | +97.2% | +83.2% | +92.7% | +100.0% | +99.8% | +99.9% | +99.9% |
| Operating Expenses? | $432.40M | $450.36M | $425.00M | $300.57M | $167.77M | $111.77M | $119.88M | $95.93M | $86.76M | $69.78M |
| Operating Income? | -$252.48M | -$220.71M | -$508.30M | $119.41M | -$105.12M | -$40.87M | -$57.12M | -$49.95M | $16.00M | -$2.01M |
| EBITDA? | -$70.53M | $144.58M | -$515.14M | $50.80M | -$99.25M | -$37.12M | -$53.09M | -$46.18M | $19.46M | -$56,236 |
| Income Before Tax | -$190.92M | $17.52M | -$591.10M | $22.49M | -$106.52M | -$60.48M | -$68.79M | -$59.86M | $20.63M | -$4.31M |
| Income Tax Expense | -$1.19M | $168.58M | -$76.60M | -$75.40M | -$3.51M | -$4.30M | $1.04M | $519,000 | $5.72M | -$1.30M |
| Net Income? | -$189.73M | -$151.06M | -$514.50M | $97.89M | -$103.01M | -$56.17M | -$69.83M | -$60.38M | $14.90M | -$3.01M |
| EPS? | $-5.53 | $-4.42 | $-15.40 | $3.01 | $-3.26 | $-1.79 | $-2.41 | $-2.28 | $0.57 | $-0.12 |
| Diluted EPS? | $-5.53 | $-4.42 | $-15.40 | $2.95 | $-3.26 | $-1.79 | $-2.41 | $-2.27 | $0.57 | $-0.12 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality